📰 Specific Antigen News

Page 2 - Specific Antigen News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Specific Antigen. Real-time updates on events, politics, business and more.

Proteomedix Agrees to Issue Labcorp Exclusive License for Proclarix Blood Test to Detect Prostate Cancer

May 22, 2023

Labcorp Plans to Develop and Commercialize the Innovative Prostate Cancer Liquid Biopsy Test in the U.S. Proteomedix, a Swiss diagnostics company committed to advancing prostate cancer care, announced

United States United Kingdom Gewinn Nur Brown Rudnick Helge Lubenow Prasanth Reddy

Source: finanznachrichten.de

Choose Health Makes More At-Home Blood Tests Available for Private Label Use

May 19, 2023

/PRNewswire/ -- Choose Health is excited to expand its popular private label product line to include additional at-home blood tests. A wide variety of...

United States Matthew Mcdermott Head Of Research Development At Choose Health Blood Sugar Height Ratio Stimulating Hormone

Source: prnewswire.com

Essential medical tests you should do

April 23, 2023

Routine check-ups help us detect a disease in its early stages which is important in the overall management and treatment outcomes.

Specific Antigen Radiological Imaging Laura Kimondo

Source: businessdailyafrica.com

Northern Nevada Sierra Medical Center Hosts Inaugural Low-Cost Community Health Fair

June 30, 2022

Northern Nevada Sierra Medical Center (SMC), will host its first community health fair on Wednesday, July 13 from 7 a.m. to 10 a.m. at 625 Innovation Drive near the intersection

United States Lipid Panel Northern Nevada Health System Chemistry Panel Northern Nevada Sierra Medical Center Longley Lane

Source: 2news.com

Modra Pharmaceuticals Presents In-Depth Data Analysis from Lower Dose Cohort in Phase 2b Study of Oral Taxane ModraDoc006/r in mCRPC Patients at 2022 ASCO Annual Meeting

May 27, 2022

ModraDoc006/r at 20-20/200-100mg dosage eliminated neutropenia and significantly decreased neuropathy while maintaining efficacy levels comparable to intravenous (IV) docetaxel Based on strong

United States Kostenloser Wertpapierhandel Colin Freund Ulka Vaishampayan Desmond James Ulkan Vaishampayan

Source: finanznachrichten.de

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Administration of Ceasalpinia bonduc seed extracts in BPH

May 26, 2022

Investigating whether the Ceasalpinia bonduc seed extracts have inhibitory potential on Testosterone Propionate (TP) induced BPH in Wistar rats.

United States Santa Clara Dan Mathew Cusabio Biotech Co Ltd Agilent Technologies Research Institute

Source: dovepress.com

Mount Sinai Health System Launches First-Ever Mobile Prostate Cancer Screening Unit in New York City

March 30, 2022

New York, NY (PRWEB) March 30, 2022 -- New York, NY (March 30, 2022) – On Friday, April 1 at 1p.m., the Milton and Caroll Petrie Department of Urology at

Community Plaza United States New York Long Island Robertf Smith Steve Harvey

Source: prweb.com

Modra Pharmaceuticals Presents Positive Phase IIb Results for ModraDoc006/r, a Boosted Oral Taxane for Patients with Metastatic Prostate Cancer, at 2022 ASCO GU Annual Meeting

February 17, 2022

Results support ModraDoc006/r as an effective, convenient, and well tolerated oral docetaxel treatment option for patients with mCRPC Response rates compare favorably to intravenous (IV) docetaxel

United States Kostenloser Wertpapierhandel Colin Freund Ulka Vaishampayan Desmond James Modra Pharmaceuticals

Source: finanznachrichten.de